TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biorecro AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
256
|
286
|
273 |
| Financial expenses |
60
|
22
|
56 |
| Earnings before taxes |
3
|
7
|
-95 |
| EBITDA |
63
|
27
|
-39 |
| Total assets |
523
|
344
|
228 |
| Current assets |
66
|
33
|
228 |
| Current liabilities |
373
|
213
|
153 |
| Equity capital |
13
|
10
|
3 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
2
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
2.5%
|
2.9%
|
1.3% |
| Turnover per employee |
128
|
72
|
91 |
| Profit as a percentage of turnover |
1.2%
|
2.4%
|
-34.8% |
| Return on assets (ROA) |
12.0%
|
8.4%
|
-17.1% |
| Current ratio |
17.7%
|
15.5%
|
149.0% |
| Return on equity (ROE) |
23.1%
|
70.0%
|
-3166.7% |
| Change turnover |
-20
|
12
|
84 |
| Change turnover % |
-7%
|
4%
|
44% |
| Chg. No. of employees |
-2
|
1
|
0 |
| Chg. No. of employees % |
-50%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.